Related Experiment Videos

Insulin inhibits vascular smooth muscle contraction at a site distal to intracellular Ca2+ concentration

A M Kahn1, A Husid, T Odebunmi

  • 1Department of Medicine, University of Texas Health Science Center, Houston, USA.

Insights

Insulin inhibits vascular smooth muscle contraction via nitric oxide synthase (NOS) and cGMP, independent of intracellular calcium levels. This finding is crucial for understanding insulin resistance in hypertensive states.

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Smooth Muscle Physiology

Background:

  • Hypertension is linked to impaired insulin sensitivity.
  • Insulin normally inhibits vascular smooth muscle (VSM) contraction.
  • Insulin resistance may contribute to excessive VSM contraction.

Purpose of the Study:

  • Investigate how insulin inhibits normal VSM contraction.
  • Determine if insulin's effect occurs downstream of intracellular calcium (Ca2+i).
  • Elucidate the role of nitric oxide synthase (NOS) and cyclic guanosine monophosphate (cGMP) in insulin's VSM inhibitory mechanism.

Main Methods:

  • Cultured canine femoral artery VSM cells were used.
  • Cells were permeabilized and exposed to ionomycin or A-23187 to induce contraction.
  • Intracellular Ca2+i and cGMP levels were measured.
  • The effects of insulin, NOS inhibitors, and guanylate cyclase inhibitors on VSM contraction were assessed.

Main Results:

  • Insulin inhibited VSM cell contraction without altering Ca2+i.
  • Insulin dose-dependently inhibited contractions in the presence of elevated Ca2+i.
  • Insulin increased cGMP production, which was blocked by a guanylate cyclase inhibitor.
  • NOS inhibitors blocked insulin's inhibitory effect on VSM contraction.

Conclusions:

  • Insulin inhibits VSM contraction through a mechanism dependent on NOS and cGMP.
  • This inhibition occurs downstream of intracellular Ca2+i.
  • Findings provide insight into VSM cellular mechanisms underlying insulin resistance.

Related Concept Videos